Aura Biosciences, Inc. (AURA)
5.07
-0.02
(-0.39%)
USD |
NASDAQ |
Jan 12, 16:00
5.11
+0.04
(+0.79%)
After-Hours: 05:50
Aura Biosciences EPS Diluted (Quarterly): -0.3963 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| 4D Molecular Therapeutics, Inc. | -1.013 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.13M |
| Total Expenses (Quarterly) | 26.13M |
| Enterprise Value | 177.85M |
| Earnings Yield | -38.03% |
| Normalized Earnings Yield | -38.03 |